Dusilová-Sulková S - Search Results

1

No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients.

Kalousová M, Kielstein JT, Hodková M, Zima T, Dusilová-Sulková S, Martens-Lobenhoffer J, Bode-Boger SM. Kalousová M, et al. Blood Purif. 2006;24(5-6):439-44. doi: 10.1159/000095360. Epub 2006 Aug 25. Blood Purif. 2006. PMID: 16940714 Clinical Trial.

2

Influence of parenteral iron therapy and oral vitamin E supplementation on neutrophil respiratory burst in chronic hemodialysis patients.

Hodkova M, Dusilova-Sulkova S, Skalicka A, Kalousova M, Zima T, Bartunkova J. Hodkova M, et al. Ren Fail. 2005;27(2):135-41. Ren Fail. 2005. PMID: 15807176

3

Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.

Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J. Kalousová M, et al. Mutat Res. 2005 Nov 11;579(1-2):37-46. doi: 10.1016/j.mrfmmm.2005.03.024. Epub 2005 Aug 5. Mutat Res. 2005. PMID: 16084533 Review.

4

Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.

Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M. Jarkovská Z, et al. Growth Horm IGF Res. 2005 Dec;15(6):369-76. doi: 10.1016/j.ghir.2005.07.004. Epub 2005 Sep 28. Growth Horm IGF Res. 2005. PMID: 16198134

5

Intravenous iron gluconate administration increases circulating PAPP-A in hemodialysis patients.

Hodkova M, Kalousova M, Dusilova-Sulkova S, Malbohan IM, Zima T. Hodkova M, et al. Ren Fail. 2005;27(6):707-11. doi: 10.1080/08860220500242868. Ren Fail. 2005. PMID: 16350822

6

Soluble receptor for advanced glycation end products in patients with decreased renal function.

Kalousová M, Hodková M, Kazderová M, Fialová J, Tesar V, Dusilová-Sulková S, Zima T. Kalousová M, et al. Am J Kidney Dis. 2006 Mar;47(3):406-11. doi: 10.1053/j.ajkd.2005.12.028. Am J Kidney Dis. 2006. PMID: 16490618

7

Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.

Hodkova M, Dusilova-Sulkova S, Kalousova M, Soukupova J, Zima T, Mikova D, Malbohan IM, Bartunkova J. Hodkova M, et al. Ren Fail. 2006;28(5):395-9. doi: 10.1080/08860220600683698. Ren Fail. 2006. PMID: 16825088 Clinical Trial.

8

Effect of hemodiafiltration on pregnancy-associated plasma protein A (PAPP-A) and related parameters.

Kalousová M, Hodková M, Dusilová-Sulková S, Uhrová J, Tesar V, Zima T. Kalousová M, et al. Ren Fail. 2006;28(8):715-21. doi: 10.1080/08860220600925412. Ren Fail. 2006. PMID: 17162432

9

Physiologic variability of vascular access blood flow for hemodialysis.

Válek M, Lopot F, Dusilová-Sulková S, Polakovic V. Válek M, et al. Blood Purif. 2008;26(5):468-72. doi: 10.1159/000157324. Epub 2008 Sep 22. Blood Purif. 2008. PMID: 18810229

10

Circulating fetuin-A predicts early mortality in chronic hemodialysis patients.

Bláha V, Mistrík E, Dusilová-Sulková S, Kalousová M, Andrýs C, Bláha M, Sobotka L. Bláha V, et al. Clin Biochem. 2009 Jul;42(10-11):996-1000. doi: 10.1016/j.clinbiochem.2009.03.021. Epub 2009 Mar 31. Clin Biochem. 2009. PMID: 19341719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters